Marshall Wace
UTHR icon

Marshall Wace’s United Therapeutics UTHR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$79.4M Buy
276,480
+63,484
+30% +$18.2M 0.09% 194
2025
Q1
$65.7M Buy
+212,996
New +$65.7M 0.08% 199
2024
Q4
Sell
-12,708
Closed -$4.55M 2820
2024
Q3
$4.55M Sell
12,708
-7,397
-37% -$2.65M 0.01% 951
2024
Q2
$6.4M Sell
20,105
-105,538
-84% -$33.6M 0.01% 820
2024
Q1
$28.9M Buy
125,643
+115,788
+1,175% +$26.6M 0.04% 340
2023
Q4
$2.17M Buy
9,855
+7,407
+303% +$1.63M ﹤0.01% 988
2023
Q3
$553K Buy
+2,448
New +$553K ﹤0.01% 1420
2023
Q1
Sell
-4,613
Closed -$1.28M 2615
2022
Q4
$1.28M Buy
+4,613
New +$1.28M ﹤0.01% 1510
2022
Q3
Sell
-2,449
Closed -$577K 3099
2022
Q2
$577K Sell
2,449
-27,151
-92% -$6.4M ﹤0.01% 2098
2022
Q1
$5.31M Buy
+29,600
New +$5.31M 0.01% 1187
2021
Q4
Sell
-21,422
Closed -$3.95M 3598
2021
Q3
$3.95M Buy
+21,422
New +$3.95M 0.02% 915
2021
Q2
Sell
-1,978
Closed -$331K 2578
2021
Q1
$331K Sell
1,978
-3,804
-66% -$637K ﹤0.01% 1788
2020
Q4
$878K Sell
5,782
-6,194
-52% -$941K ﹤0.01% 1136
2020
Q3
$1.21M Sell
11,976
-13,661
-53% -$1.38M 0.01% 923
2020
Q2
$3.1M Buy
+25,637
New +$3.1M 0.02% 605
2020
Q1
Sell
-5,566
Closed -$490K 2037
2019
Q4
$490K Buy
+5,566
New +$490K ﹤0.01% 1135
2019
Q1
Sell
-17,819
Closed -$1.94M 2060
2018
Q4
$1.94M Buy
+17,819
New +$1.94M 0.02% 725
2018
Q3
Sell
-3,327
Closed -$376K 1287
2018
Q2
$376K Buy
+3,327
New +$376K 0.01% 604
2016
Q2
Sell
-67,886
Closed -$7.57M 1168
2016
Q1
$7.57M Buy
67,886
+65,899
+3,317% +$7.34M 0.07% 257
2015
Q4
$311K Sell
1,987
-123,530
-98% -$19.3M ﹤0.01% 872
2015
Q3
$16.5M Buy
125,517
+55,797
+80% +$7.32M 0.2% 127
2015
Q2
$12.1M Sell
69,720
-2,864
-4% -$498K 0.16% 151
2015
Q1
$12.5M Sell
72,584
-199,381
-73% -$34.4M 0.16% 162
2014
Q4
$35.2M Buy
271,965
+202,820
+293% +$26.3M 0.46% 51
2014
Q3
$8.9M Buy
69,145
+22,569
+48% +$2.9M 0.13% 201
2014
Q2
$4.12M Buy
+46,576
New +$4.12M 0.06% 290